[{"address1": "One Research Court", "address2": "Suite 450", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "240 403 4212", "website": "https://www.shuttlepharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Anatoly  Dritschilo M.D.", "age": 79, "title": "Co-Founder, CEO & Chairman of the Board", "yearBorn": 1944, "fiscalYear": 2023, "totalPay": 399175, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter Dale Dritschilo M.B.A., M.D.", "age": 54, "title": "President & COO", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 314012, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mira  Jung Ph.D.", "age": 74, "title": "Co-Founder & Chief Scientific Officer for Biology", "yearBorn": 1949, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gene  Jung Esq.", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.42, "open": 0.42, "dayLow": 0.4, "dayHigh": 0.425, "regularMarketPreviousClose": 0.42, "regularMarketOpen": 0.42, "regularMarketDayLow": 0.4, "regularMarketDayHigh": 0.425, "volume": 10187, "regularMarketVolume": 10187, "averageVolume": 119990, "averageVolume10days": 51990, "averageDailyVolume10Day": 51990, "bid": 0.294, "ask": 0.546, "bidSize": 200, "askSize": 200, "marketCap": 6811776, "fiftyTwoWeekLow": 0.35, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 0.405, "twoHundredDayAverage": 0.597135, "currency": "USD", "enterpriseValue": 2677918, "floatShares": 9545209, "sharesOutstanding": 16069300, "sharesShort": 65874, "sharesShortPriorMonth": 87690, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.0041, "heldPercentInsiders": 0.44438, "heldPercentInstitutions": 0.02121, "shortRatio": 1.62, "shortPercentOfFloat": 0.0069, "bookValue": 0.252, "priceToBook": 1.6821429, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -6592723, "trailingEps": -0.44, "enterpriseToEbitda": -0.455, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SHPH", "underlyingSymbol": "SHPH", "shortName": "Shuttle Pharmaceuticals Holding", "longName": "Shuttle Pharmaceuticals Holdings, Inc.", "firstTradeDateEpochUtc": 1661952600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7d533843-75d5-319f-b923-9ea3e624e2b7", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.4239, "recommendationKey": "none", "totalCash": 5463631, "totalCashPerShare": 0.325, "ebitda": -5885571, "totalDebt": 1087694, "quickRatio": 5.257, "currentRatio": 5.366, "debtToEquity": 26.818, "returnOnAssets": -0.5043, "returnOnEquity": -1.1237301, "freeCashflow": -2748698, "operatingCashflow": -5581147, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-10"}]